Menchon Grégory, Maveyraud Laurent, Czaplicki Georges
Laboratory of Biomolecular Research, Paul Scherrer Institute, Villigen PSI, Switzerland.
Institute of Pharmacology and Structural Biology, UMR 5089, University of Toulouse III, Toulouse, France.
Methods Mol Biol. 2018;1762:145-178. doi: 10.1007/978-1-4939-7756-7_9.
Rational drug design is essential for new drugs to emerge, especially when the structure of a target protein or catalytic enzyme is known experimentally. To that purpose, high-throughput virtual ligand screening campaigns aim at discovering computationally new binding molecules or fragments to inhibit a particular protein interaction or biological activity. The virtual ligand screening process often relies on docking methods which allow predicting the binding of a molecule into a biological target structure with a correct conformation and the best possible affinity. The docking method itself is not sufficient as it suffers from several and crucial limitations (lack of protein flexibility information, no solvation effects, poor scoring functions, and unreliable molecular affinity estimation).At the interface of computer techniques and drug discovery, molecular dynamics (MD) allows introducing protein flexibility before or after a docking protocol, refining the structure of protein-drug complexes in the presence of water, ions and even in membrane-like environments, and ranking complexes with more accurate binding energy calculations. In this chapter we describe the up-to-date MD protocols that are mandatory supporting tools in the virtual ligand screening (VS) process. Using docking in combination with MD is one of the best computer-aided drug design protocols nowadays. It has proved its efficiency through many examples, described below.
合理药物设计对于新药的出现至关重要,尤其是当靶蛋白或催化酶的结构通过实验已知时。为此,高通量虚拟配体筛选活动旨在通过计算发现新的结合分子或片段,以抑制特定的蛋白质相互作用或生物活性。虚拟配体筛选过程通常依赖于对接方法,该方法能够预测分子以正确构象和尽可能高的亲和力与生物靶标结构的结合。对接方法本身并不充分,因为它存在几个关键限制(缺乏蛋白质灵活性信息、没有溶剂化效应、评分函数不佳以及分子亲和力估计不可靠)。在计算机技术与药物发现的交叉领域,分子动力学(MD)允许在对接协议之前或之后引入蛋白质灵活性,在水、离子甚至类膜环境存在的情况下优化蛋白质-药物复合物的结构,并通过更准确的结合能计算对复合物进行排序。在本章中,我们描述了在虚拟配体筛选(VS)过程中必不可少的最新分子动力学协议。将对接与分子动力学结合使用是当今最佳的计算机辅助药物设计协议之一。通过以下所述的许多实例,它已证明了其有效性。